Home

Results 1 - 10 of 133,014 for medicinal advantages. Search took 2.735 seconds.  
Sort by date/Sort by relevance
Second, the Regional Director emphasized, is the need to fully operationalize the SEARN initiative and take advantage of comparative strengths in regulatory capacity. (...) “There is likewise a pressing need to take advantage of TRIPS flexibilities and other opportunities in intellectual property and trade rules.” (...) Good data enable decision-makers to know how many people cannot access the medicines they need and where medicines are not available; whether unsafe or ineffective products are on sale, and the scale of misuse or wastage of medicines.”
Language:English
Score: 1168489.1 - https://www.who.int/southeasta...medicines-available-to-all-who
Data Source: un
After an expository account of the events that led to the amendment, the paper looks at the options presented by Article 31bis against the membership matrix nd other contextual factors obtaining in the SADC as a regional trade agreement (RTA) and concludes that it is now possible for SADC to rely on Article 31bis in order to ameliorate the precarious access to essential medicines situation in the region. The options presented here may inspire other similarly placed RTAs in Africa and the rest of the developing world to take advantage of Article 31bis. (...) SADC Members may therefore use the existence of similar health problems to take advantage of the procurement options presented by Article 31bis. (...) The last two measures therefore present an opportunity for SADC Members to take advantage of Article 31bis and produce essential medicines (as generics) for local use or export within the region.
Language:English
Score: 1158299.6 - https://www.wto.org/english/tr..._11_2018_african_edition_e.pdf
Data Source: un
One would expect LDCs to take advantage of these transition periods and reform their laws to exclude pharmaceuticals from patent protection. (...) The above extensions, however, do not preclude the need for prospective domestic legislative reform to take advantage of existing TRIPS flexibilities. The need to reflect on the progress Malawi has made towards taking advantage of the TRIPS flexibilities is imperative considering the fact that the Doha Declaration, the 30th August 2003 Decision (on the Implementation of paragraph 6 of the Doha Declaration) and a subsequent decision of the WTO Council in proposing a congruent TRIPS amendment, Article 31bis, present a window of opportunity for countries with insufficient or no manufacturing capacity to take full advantage of TRIPS-based flexibilities to import affordable, good quality medication for their citizens. 35 Chikosa Banda, Robert-Lewis Lettington, A survey of policy and Practice on the Use of Access to Medicines-Related TRIPS These flexibilities include compulsory licensing, parallel importation and deferral of the patenting of pharmaceuticals to 2016. (...) This has impaired Malawi’s ability to take full advantage of TRIPS flexibilities to promote access to medicines objectives.
Language:English
Score: 1157429.1 - https://www.wto.org/english/tr...r_8_2018_african_edition_e.pdf
Data Source: un
The establishment of a free trade area that removed duties and other tariffs from products produced and marketed to member states in the region presents a huge market potential which Plus Five is well positioned to take advantage of. The fact that 75% of pharmaceuticals consumed are imported from outside the region presents a rare opportunity for a serious regional player to take advantage of. • Local pharmaceutical market size was estimated to be more than US$245 million in 2014. (...) The pharmaceutical market is therefore expected to double in the next few years. 4 SHARE OF DOMESTIC MARKET BY MARKET COMPONENT Imported Medicines 50% Donated Medicines 40% Medicines produced by Local Industry 10% 2014 5 MARKET COMPONENT 2014 USD Millions Imported Medicines 123.6 Donated Medicines 96.8 Medicines Produced by Local Industry 24.1 TOTAL 244.5 The Zimbabwe market was, in the 2014 market demand survey carried out by UNIDO, estimated to be $244.5 million with: imported medicines $123.6 million (50%); Donated Medicines $96.8 million (40%) and Medicines Produced by local industry $24.1 million(10%). (...) This gives local companies a price advantage. • Anti-Retroviral (ARV) Medicines for HIV/AIDS procured by the National AIDS Council (NAC) preference is given to local manufacturers before imported product.
Language:English
Score: 1116389.8 - https://www.unido.org/sites/de...ntation_01032018%20Bonn%20.pdf
Data Source: un
These are particularly advantageous for low-income countries as, unlike warfarin, they do not require regular monitoring; Biologics and their respective biosimilars for chronic inflammatory conditions such as rheumatoid arthritis and inflammatory bowel diseases; Heat-stable carbetocin for the prevention of postpartum haemorrhage. This new formulation has similar effects to oxytocin, the current standard therapy, but offers advantages for tropical countries as it does not require refrigeration; Not all submissions to the EML Committee are included in the list. For example, medicines for multiple sclerosis submitted for inclusion were not listed.
Language:English
Score: 1111785.9 - https://www.who.int/news/item/...gnostics-lists-published-today
Data Source: un
The 12 medicines WHO added to the new Medicines List for five cancer therapies are regarded as the best in terms of survival rates to treat melanoma, lung, prostate, multiple myeloma and leukemias cancers. (...) This new formulation has similar effects to oxytocin, the current standard therapy, but offers advantages for tropical countries as it does not require refrigeration; Not all submissions to the EML Committee are included in the list. For example, medicines for multiple sclerosis submitted for inclusion were not listed.
Language:English
Score: 1106100.8 - https://www.who.int/news/item/...-and-improve-affordable-access
Data Source: un
Second, Nepal had witnessed a smooth growth trend in export of herbal products, indicating one of the most potential areas of comparative advantage. That had resulted in an increased number of foreign investors — particularly the popular Indian herbal product manufacturers — being attracted to Nepal to exploit the country’s favourable climate and abundance of a wide variety of aromatic plants and medicinal herbs. (...) The local and external players and their roles  Although the share of herbal products in Nepal’s export basket seemed to be modest, Tiwari expected three points of comparative advantage for his company to boost trade in this product line. (...) Second, these products had been enjoying duty advantages, as they were exempted from the customs duties under the generalized system of preferences (GSP) applying to Nepalese goods in all major international markets.
Language:English
Score: 1102422.4 - https://www.wto.org/english/re...p_e/casestudies_e/case31_e.htm
Data Source: un
WHO | Philosophy, Ethics and Humanities in Medicine, Austin, Texas, USA Access Home Alt+0 Content Alt+2 Search Search Submit Language عربي 中文 English Français Русский Español Menu Global Health Workforce Alliance About the Alliance Members & partners Country responses Knowledge centre Media centre Global Forums Philosophy, Ethics and Humanities in Medicine, Austin, Texas, USA Member profile Philosophy, Ethics, and Humanities in Medicine (PEHM) is an open access, peer-reviewed online journal that encompasses all aspects of the philosophy of medicine, biology, and the ethical aspects of clinical practice and research. (...) Author's submit research to PEHM to take advantage of rapid peer review, publication immediately upon acceptance, open access with retained copyright on journal website, high visibility within the field, and permanence through open access archives. (...) Philosophy, Ethics and Humanities in Medicine, Austin, Texas, USA You are here: Global Health Workforce Alliance Members and Partners Full list of all members and partners Quick Links Sitemap Global Health Workforce Alliance About the Alliance Members & partners Country responses Knowledge centre Media centre Forums Resources About the Alliance Join us Alliance Q&A Feedback Privacy Visit WHO web site © WHO 2022
Language:English
Score: 1098453.4 - https://www.who.int/workforcea...artners/member_list/pehmed/en/
Data Source: un
UN Womenwatch | Rural Women - SPFII: Good Practice Example - Projects implemented under the Trust Fund for the Second Decade of the World's Indigenous Peoples UN System & Rural Women Introduction Education & Training Health Access Food Security Social Protection Decent Work Markets Climate Change Policy Decision-making FAO Comparative Advantage Good Practices 1 Good Practices 2 IFAD Comparative Advantage Good Practices ITC-ILO Comparative Advantage SPFII Comparative Advantage Good Practices UNCTAD Comparative Advantage UNDP Comparative Advantage Good Practices UNESCO Comparative Advantage UNFPA Comparative Advantage Good Practices 1 Good Practices 2 UN Women Comparative Advantage Good Practices WFP Good Practices WHO Comparative Advantage Good Practices Joint Efforts Facts & Figures Related News Related Resources PFII: Good Practice Example Projects Implemented under the Trust Fund for the Second Decade of the World's Indigenous Peoples On 22 December 2004, the General Assembly adopted Resolution A/RES/59/174 for a Second International Decade, which commenced on 1 January 2005. (...) These groups managed to conserve their culture and use it to their advantage, benefiting from the creation of "manyatta", cultural villages that are self-sustaining including through revenues generated from handicrafts, in particular traditional bead work. (...) Traditional knowledge on the value of indigenous medicinal species and wildlife was also shared with the youth through experiential learning in the forest.
Language:English
Score: 1094258.4 - https://www.un.org/womenwatch/...women/spfii-good-practice.html
Data Source: un
UN Womenwatch | Rural Women - UNCTAD: Comparative Advantage UN System & Rural Women Introduction Education & Training Health Access Food Security Social Protection Decent Work Markets Climate Change Policy Decision-making FAO Comparative Advantage Good Practices 1 Good Practices 2 IFAD Comparative Advantage Good Practices ITC-ILO Comparative Advantage SPFII Comparative Advantage Good Practices UNCTAD Comparative Advantage UNDP Comparative Advantage Good Practices UNESCO Comparative Advantage UNFPA Comparative Advantage Good Practices 1 Good Practices 2 UN Women Comparative Advantage Good Practices WFP Good Practices WHO Comparative Advantage Good Practices Joint Efforts Facts & Figures Related News Related Resources United Nations Conference on Trade and Development (UNCTAD): Comparative Advantage Primary Mandate/Concentration in Relation to Rural Women UNCTAD is the focal point within the United Nations for the integrated treatment of trade and development and the interrelated issues of finance, investment, technology and sustainable development. (...) In line with the BioTrade concept, the communitarian business Jambi Kiwa (Producers Association of Medicinal Plants, Chimborazo, Ecuador) focuses on the transformation and commercialization of medicinal and aromatic plants sold at the local and national market in Ecuador.
Language:English
Score: 1088229.5 - https://www.un.org/womenwatch/...tad-comparative-advantage.html
Data Source: un